Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

September 14, 2017

INDIVIOR INC. et al v. TEVA PHARMACEUTICALS USA, INC.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 28, 2018

    Teva Can't Move IP Suits Over Opioid Treatment Drug To Del.

    A New Jersey federal judge on Monday refused to transfer to Delaware a group of Indivior Inc.'s lawsuits that accuse Dr. Reddy's Laboratories, Teva Pharmaceuticals and Alvogen Pine Brook Inc. of pursuing generic versions of brand name opioid addiction treatment drug Suboxone, infringing its patents.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login